Craig F. Courtemanche Jr. - Dec 1, 2023 Form 4 Insider Report for PROCORE TECHNOLOGIES, INC. (PCOR)

Signature
/s/ Benjamin C. Singer, Attorney-in-Fact
Stock symbol
PCOR
Transactions as of
Dec 1, 2023
Transactions value $
-$4,074,111
Form type
4
Date filed
12/5/2023, 08:59 PM
Previous filing
Nov 27, 2023
Next filing
Dec 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCOR Common Stock Sale -$875K -14.8K -0.47% $59.02 3.11M Dec 1, 2023 See Footnote F1, F2, F3
transaction PCOR Common Stock Sale -$1.88M -31.4K -1.01% $59.86 3.08M Dec 1, 2023 See Footnote F1, F3, F4
transaction PCOR Common Stock Sale -$1.05M -17.3K -0.56% $60.77 3.06M Dec 1, 2023 See Footnote F1, F3, F5
transaction PCOR Common Stock Sale -$49.8K -842 -0.07% $59.14 1.26M Dec 1, 2023 See Footnote F1, F6, F7
transaction PCOR Common Stock Sale -$83.9K -1.4K -0.11% $59.90 1.26M Dec 1, 2023 See Footnote F1, F7, F8
transaction PCOR Common Stock Sale -$55.2K -908 -0.07% $60.77 1.26M Dec 1, 2023 See Footnote F1, F7, F9
transaction PCOR Common Stock Sale -$24.7K -418 -0.08% $59.06 541K Dec 1, 2023 See Footnote F1, F10, F11
transaction PCOR Common Stock Sale -$36.8K -613 -0.11% $59.96 540K Dec 1, 2023 See Footnote F1, F11, F12
transaction PCOR Common Stock Sale -$19.4K -319 -0.06% $60.83 540K Dec 1, 2023 See Footnote F1, F11, F13
holding PCOR Common Stock 813K Dec 1, 2023 Direct
holding PCOR Common Stock 23.7K Dec 1, 2023 Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a 10b5-1 plan dated June 7, 2023.
F2 The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $58.53 to $59.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Shares are held by Craig F. Courtemanche and Hillary Courtemanche Family Trust dated as of November 1, 2012.
F4 The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $59.54 to $60.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $60.56 to $60.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $58.59 to $59.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 Shares are held of record by First Republic Trust Company of Delaware TTEE Courtemanche 2021 Irrevocable Trust UA DTD 6/10/2021.
F8 The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $59.60 to $60.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F9 The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $60.61 to $60.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F10 The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $58.59 to $59.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F11 Shares are held of record by The Courtemanche 2016 Irrevocable Trust.
F12 The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $59.61 to $60.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F13 The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $60.70 to $60.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.